Who We Are
Hetero Plasma Sciences is a Greenfield Plasma Fractionation facility established at Kothur, Hyderabad, and built in compliance with cGMP standards and WHO guidelines. The facility is designed to address the growing demand for Plasma Derived Medicinal Products (PDMPs), reflecting Hetero’s commitment to meeting critical and unmet healthcare needs.
World-Class Manufacturing
cGMP Compliant Facility with approvals from WHO-GMP & CDSCO (Central Drugs Standard Control Organization) to manufacture the PDMPs for both Domestic Distribution and global markets.
Rigorous Quality Standards
Comprehensive Plasma testing with Serology, CMIA and NAT (Nucleic Acid Testing) for Viral Safety and Finished Product testing to meet Indian, European and British pharmacopoeia standards.
Advanced Technology
Proven Hybrid Technology Combining A Modified Cohn's Fractionation Process With Modern Chromatographic Techniques, Supported By Multiple Orthogonal Virus Inactivation / Removal Steps To Ensure The Highest Levels Of Product Safety.
Licensed Collection Network
Drug Controller General Of India (DCGI) Approval For Collection Of Plasma From A Well-Established Network Of Licensed Blood Centers Across India, Ensuring Regulatory Compliance And A Reliable Supply Chain.
Why Hetero Plasma Sciences
Addressing India's Critical Need
There is a substantial gap between plasma product availability and demand in India. Hetero Plasma Sciences was established to bridge this gap, ensuring every unit of this rare commodity is utilized to its fullest potential.
Our Commitment
- Meeting the highest safety and quality standards
- Optimizing every unit of collected plasma
- Delivering life-saving therapies for chronic and acute conditions
- Contributing to community well-being through accessible healthcare
Part of a Legacy
Backed by Hetero Group's 30 years of pharmaceutical expertise, presence in 140+ countries, and leadership as the world's largest producer of anti-retroviral drugs
